Search
for
Sort by
Research 451–480 of 1000+
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Diagnosis of Polycystic Ovary Syndrome using Free Testosterone levels via Surface Enhanced Raman Spectroscopy Induced by Gold Nanostar
- Study of effect of myoinositol on menstrual irregularities and skin problems in polycystic ovarian syndrome cases
- Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
- Case Report: Postmenopausal hyperandrogenism misled by adrenal incidentaloma: a rare case of androgen-secreting ovarian adult granulosa cell tumor and clinical implications
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Understanding of a Veiled Illness: Evaluation of Polycystic Ovarian Syndrome awareness (PCOS) in Young Female Students of Karachi.
- A MODERN VIEW OF THE POLYCYSTIC OVARIAN SYNDROME
- 5-Alpha reductase deficiency
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
- Chapter 23. Therapeutic Control of Androgen Action
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- The role of androgen and androgen receptor in skin-related disorders